Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Double Dummy, Randomised, Parallel Group, Multicentre Study to Compare the Efficacy and Safety of Flutiform pMDI With Fluticasone pMDI and With Seretide pMDI in Paediatric Subjects Aged 5 to Less Than 12 Years With Moderate to Severe Persistent Reversible Asthma

NCT01511367 is registered in ClinicalTrials.gov with Mundipharma Research Limited as lead sponsor.

NCT NCT01511367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01511367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Double Dummy, Randomised, Parallel Group, Multicentre Study to Compare the Efficacy and Safety of Flutiform pMDI With Fluticasone pMDI and With Seretide pMDI in Paediatric Subjects Aged 5 to Less Than 12 Years With Moderate to Severe Persistent Reversible Asthma
Lead sponsor
Mundipharma Research Limited
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
November 30, 2013
Enrollment
498 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asthma